High Note Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

High Note Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$76K	Hold	595	–	–	0.01%	169
2025 Q4	$72.5K	Hold	595	–	–	0.01%	172
2025 Q3	$59.6K	Hold	595	–	–	0.01%	170
2025 Q2	$49.3K	Sell	595 -2,297	-79%	-$183K	0.01%	174
2025 Q1	$235K	Sell	2,892 -1,688	-37%	-$151K	0.06%	90
2024 Q4	$412K	Sell	4,580 -948	-17%	-$91.8K	0.11%	77
2024 Q3	$546K	Hold	5,528	–	–	0.16%	66
2024 Q2	$513K	Hold	5,528	–	–	0.16%	67
2024 Q1	$525K	Buy	+5,528	New	+$513K	0.17%	67
2023 Q4	–	Sell	-14,432	Closed	-$1.05M	–	95
2023 Q3	$1.05M	Buy	14,432 +851	+6%	+$68K	0.44%	43
2023 Q2	$1.13M	Sell	13,581 -601	-4%	-$50.3K	0.46%	43
2023 Q1	$1.08M	Buy	14,182 +850	+6%	+$70.5K	0.45%	45
2022 Q4	$1.11M	Buy	13,332 +240	+2%	+$19.4K	0.46%	46
2022 Q3	$1.06M	Buy	13,092 +339	+3%	+$28.6K	0.42%	49
2022 Q2	$947K	Buy	12,753 +2,792	+28%	+$210K	0.37%	54
2022 Q1	$895K	Buy	+9,961	New	+$920K	0.32%	55

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

High Note Wealth's XBI Position: Q1 2026 in Review

High Note Wealth held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 595 shares worth $76K. The position accounts for 0.01% of the portfolio, ranked #169.

High Note Wealth first reported a position in XBI in Q1 2022 and has held it in 16 quarters since. The position peaked at $1.13M in Q2 2023. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

High Note Wealth held 595 shares of State Street SPDR S&P Biotech ETF worth $76K as of Q1 2026.
High Note Wealth left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of High Note Wealth's portfolio in Q1 2026, its #169 holding.
High Note Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 16 quarters since.
High Note Wealth's State Street SPDR S&P Biotech ETF position peaked at $1.13M in Q2 2023.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on High Note Wealth's 13F filing for Q1 2026, filed 11 May 2026.